Global Footprint Texcell’s presence across France, Germany and the United States, plus a dedicated expansion to Frederick, Maryland, enables regional development programs and streamlined project management for clinical studies and GMP manufacturing across jurisdictions.

Viral Safety Leader A comprehensive viral safety and gene therapy support package including viral clearance studies, a wide range of assays, biodistribution testing and expertise with ATMP vectors positions Texcell as a go to partner for clients developing viral vectors, cell therapies or vaccines.

GMP Cell Banking GMP cell banking capabilities (RCB, MCB, WCB) with dedicated filling lines and in house viral safety checks provide end to end support for early to late stage biologics and cell therapy programs seeking scalable manufacturing readiness.

Immunogenicity Focus A broad immunogenicity and immunotoxicology offering including ADA, TK/PK, neutralizing antibody testing and potent readouts (ELISA, flow cytometry, ELISpot) enables customers to address pivotal safety and efficacy questions in preclinical and clinical studies.

Strategic Partnerships Texcell has established credibility through collaborations with Summitpharma, Valo Therapeutics and other industry partners, suggesting opportunities to pursue joint programs or multi phase projects with biotech and pharma companies seeking proven CRO support.